Welcome.
Are you a healthcare professional?

This website contains promotional information for Chiesi's respiratory products, and is intended solely for UK healthcare professionals. Please confirm below, or go back to the home page.

UK-RES-2000248 Feb 2020

You are now leaving Chiesi's website

By clicking this link, you will be taken to a website that is not owned or controlled by Chiesi. Chiesi is not responsible for the content provided on that site.

Continue
Go back

UK-RES-2000003 Jan 2020

INTENDED FOR UK HEALTHCARE PROFESSIONALS
Fostair® logo (beclometasone/formoterol) Extrafine formulation 100/6 & 200/6
Background

The cost of Fostair1

trimbow_subheader-mobile
Low dose £14.66*; Medium dose £29.32*

*Cost per 30 days of treatment.1

30 day acquisition costs of ICS/LABA combination inhalers based on list price – COPD

This graph does not imply clinical comparability

30 day cost comparison1

Bar chart data for Low dose (200-500mcg BDP)

*Fostair pMDI and NEXThaler 100/6 are licensed for patients with severe COPD (FEV1 <50% predicted). Full licensed indication can be found in the Prescribing Information.
ICS: Inhaled corticosteroid; LABA: Long-acting β2-agonist.
O.D.: Once daily; B.D.: Twice daily.

Seretide®, Accuhaler®, Relvar® and Ellipta® are registered trademarks of the GlaxoSmithKline Group of Companies. AirFluSal® and Forspiro® are registered trademarks of Sandoz Limited. Symbicort® and Turbohaler® are registered trademarks of AstraZeneca AB Limited. DuoResp® and Spiromax® are registered trademarks of Teva Pharmaceuticals Europe and are used under licence. Fobumix® and Easyhaler® are registered trademarks of Orion Pharma UK Limited. Fusacomb® is a registered trademark of Orion Corporation. Stalpex® is a registered trademark of Glenmark Pharmaceuticals Europe Limited.

Prices correct as of February 2020.

UK-FTB-2000007 Feb 2020

References:
1.MIMS Online. Available from: www.mims.co.uk Accessed February 2020.

For additional information to share with your patients who have been prescribed Fostair NEXThaler or Fostair pMDI please visit our Fostair NEXThaler patient and carer site or Fostair pMDI patient and carer site.

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Chiesi Ltd on 0800 0092329 (UK), 1800 817459 (IE) PV.UK@Chiesi.com.